Back to search

Drugscience Trading Ltd

13881874

active
Private Limited Company
Companies House
Health Score
70 / 100

Some Concerns

30/30
Filing
0/30
Financial
40/40
Risk
  • Negative net worth (-10)

Details

CAMBURGH HOUSE, CANTERBURY, CT1 3DN
Incorporated 31/01/2022

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

74909
Other professional, scientific and technical activities

Officers

Mr David John Nutt

director · Since 05/03/2024

ACADEMIC

BRITISH · ENGLAND · Age 75

Dr Anne Katrin Schlag

director · Since 05/03/2024

CEO

GERMAN · UNITED KINGDOM · Age 52

Persons with Significant Control

Drugscience Ltd

75–100% shares
75–100% votes
Appoint directors

Camburgh House, 27 New Dover Road, Canterbury, CT1 3DN

Reg: 08032149 · United Kingdom · Private Company Limited By Guarantee

Notified 31/01/2022

CompanyRankvs 54751+ SIC 74909 peers
30

Financial strength1th percentile among SIC peers · 0/25
Employees69th percentile among SIC peers · 10/15
LiquidityNo balance sheet data · 0/20
Longevity5 years trading (max 15) · 5/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength0/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees10/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity0/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity5/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 30/06/2025

Net Worth

-£423k

Balance sheet strength

Cash

Cash in the bank

Net Current Assets

-£423k

Working capital

Current Assets

Current Liabilities

£423k

Debtors

£74k

2avg. employees+1

Balance Sheet

Assets less current liabilities-£423k
Prepared with Sage Accounts Production Advanced 2024 - FRS102_2024

EstimatesDerived

YearCurrent RatioImplied Profit
2025+£11k
2024-£37k
20230.03

Derived from filed accounts. Not audited figures.